CSIMarket
 
Momenta Pharmaceuticals inc   (MNTA)
Other Ticker:  
 

Momenta Pharmaceuticals inc

Business Description


Momenta Pharmaceuticals Inc. is a biotechnology company focused on discovering and developing novel drugs to address unmet medical needs. The company was founded in 2001 and is headquartered in Cambridge, Massachusetts.

Momenta specializes in the characterization and engineering of complex molecules, with a particular emphasis on analyzing the structure and function of complex sugars called glycoproteins. Glycoproteins are critical for a variety of biological processes, including immune responses, cell signaling, and disease progression.

The company*s core technology platform, called GlycoNet, uses advanced analytical techniques to gain a deeper understanding of glycoproteins and their interactions with the immune system. This enables Momenta to identify potential therapeutic targets and develop innovative drugs that can modulate these interactions.

One of Momenta*s most notable achievements is the development of a generic version of Lovenox, an injectable blood thinner. Lovenox is a complex glycoprotein, and Momenta*s biosimilar, known as M-Enoxaparin, received regulatory approval in several countries. This was the first generic version of a complex biologic to gain approval, demonstrating the company*s expertise in glycoprotein analysis and engineering.

In addition to biosimilars, Momenta is also focused on developing novel drugs for immune-mediated diseases, including autoimmune disorders, cancer, and rare diseases. The company*s pipeline includes candidates targeting specific glycoproteins involved in these diseases, with the goal of developing safe and effective treatments.

Momenta*s research and development efforts are supported by collaborations with leading academic institutions and pharmaceutical companies. These collaborations allow for the exchange of knowledge and resources, further enhancing the company*s ability to discover and develop innovative drugs.

Overall, Momenta Pharmaceuticals Inc. is a biotechnology company at the forefront of glycoprotein analysis and engineering. With a focus on developing drugs for immune-mediated diseases and a history of successful biosimilar development, the company has positioned itself as a leader in the biopharmaceutical industry.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com